CALA (Calithera Biosciences) Accumulated Depreciation: $-3.53 Mil (As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Calithera Biosciences Accumulated Depreciation?

Calithera Biosciences CALA Accumulated Depreciation is $-3.53 Mil as of Dec. 2022.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Calithera Biosciences's quarterly accumulated depreciation stayed the same from Jun. 2022 ($0.00 Mil) to Sep. 2022 ($0.00 Mil) but then increased from Sep. 2022 ($0.00 Mil) to Dec. 2022 ($-3.53 Mil).

Calithera Biosciences's annual accumulated depreciation declined from Dec. 2020 ($-3.41 Mil) to Dec. 2021 ($-3.29 Mil) but then increased from Dec. 2021 ($-3.29 Mil) to Dec. 2022 ($-3.53 Mil).

Calithera Biosciences Accumulated Depreciation Related Terms

Calithera Biosciences Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Calithera Biosciences's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Calithera Biosciences Accumulated Depreciation Chart

Calithera Biosciences Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.74 -3.20 -3.41 -3.29 -3.53

Calithera Biosciences Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.29 0.00 0.00 0.00 -3.53

Calithera Biosciences Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-3.53 Mil mean?
Calithera Biosciences (CALA) has a Accumulated Depreciation of $-3.53 Mil as of Dec. 2022. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Calithera Biosciences and its competitors.
Is Calithera Biosciences' Accumulated Depreciation too high?
Calithera Biosciences' current Accumulated Depreciation is $-3.53 Mil.
How does Calithera Biosciences' Accumulated Depreciation compare to PPCB and QBIO?
Calithera Biosciences' Accumulated Depreciation of $-3.53 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Diversified Financial Services company?
A good Accumulated Depreciation depends on the Diversified Financial Services industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Calithera Biosciences and its competitors. Calithera Biosciences's current Accumulated Depreciation is $-3.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Calithera Biosciences stock overvalued right now?
Calithera Biosciences (CALA) has a current Accumulated Depreciation of $-3.53 Mil. The current Accumulated Depreciation is $-3.53 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Calithera Biosciences (CALA), the current Accumulated Depreciation is $-3.53 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Calithera Biosciences Business Description

Address 343 Oyster Point Boulevard, Suite 200, South San Francisco, CA, USA, 94080
Calithera Biosciences Inc is a shell company.